India restricts all export of Trump’s ‘game changer’ hydroxychloroquine COVID-19 drug Kumar Jeetendra | April 5, 2020 India put a complete prohibition on export of hydroxychloroquine, a Malaria fever drug that U.S. President Donald Trump has touted as a “distinct advantage” in the battle against Covid-19. Export of the drugs and its details have been precluded “with no special cases” and with quick impact, India’s Directorate General of Foreign Trade said in …
Novartis scraps manage Aurobindo Pharma in the wake of neglecting to get FTC gesture Kumar Jeetendra | April 2, 2020 Novartis AG said on Thursday it had rejected the offer of its US dermatology and nonexclusive pill advantages for India’s Aurobindo Pharma Ltd subsequent to neglecting to get endorsement from a US controller. Novartis said the choice to end the offer of Sandoz US’s nonexclusive oral solids and dermatology organizations was taken after the organizations …
Torrent Group submits Rs 100 cr to battle COVID-19 pandemic Kumar Jeetendra | March 31, 2020 Torrent Group has submitted Rs 100 crores to battle COVID-19 pandemic in India, it said in an announcement. The Ahmedabad-headquartered organization said it would contribute Rs 50 crore to the PM – CARES Fund and extra Rs 50 cr under different activities concerning the pandemic. The store will be used to give basic medications to …
Sun Pharma to give Rs 25 cr worth medications, sanitisers to battle coronavirus Kumar Jeetendra | March 28, 2020 Sun Pharmaceutical NSE – 0.01 % Industries Ltd has resolved to give Rs 25 crore worth of Hydroxychloroquine (HCQS), Azithromycin, other related medications and hand sanitisers to help India’s battle against coronavirus pandemic, as indicated by an organization articulation. The national team for COVID-19 comprised by Indian Council of Medical Research has suggested HCQS as …
Pharma major Cipla gets USFDA gesture for generic oral heartburn sedate Kumar Jeetendra | March 26, 2020 Medication major Cipla on Thursday said it has gotten last endorsement from the US wellbeing controller for nonexclusive Esomeprazole for oral suspension utilized for treatment of gastroesophageal reflux illness. The organization has gotten last endorsement for its contracted new medication application (ANDA) for Esomeprazole for oral suspension in the qualities of 10mg, 20mg and 40mg …
Chinese firms continue fare of pharma contributions to India Kumar Jeetendra | March 26, 2020 In what could be uplifting news for Indian medication producers, the import of Active pharmaceutical ingredients (APIs) and other crude materials from China has continued. Following the flare-up of Covid-19 in China, fare of crude materials from that nation to India was upset as most producers stopped tasks. “The import of crude materials from China …
Gilead’s potential coronavirus treatment gets FDA’s orphan medication mark Kumar Jeetendra | March 24, 2020 Gilead Sciences’ trial sedate remdesivir, seen as one of the all the more encouraging potential medicines for the coronavirus, on Monday got the vagrant medication assignment from the U.S. Food and Drug Administration. The declaration comes days after U.S. President Donald Trump approached the FDA to streamline its endorsement procedure for medications, for example, remdesivir, …
Novartis to give malaria drug in battle against coronavirus Kumar Jeetendra | March 23, 2020 Novartis will give enough dosages of jungle fever tranquilize hydroxychloroquine to treat a few million patients in the battle against the coronavirus, in the event that it wins endorsement, the Swiss organization said on Friday. There are no immunizations or medicines endorsed for the illness, yet there is at present a 1,500-man preliminary, drove by …
Biocon gets EIR from USFDA for assembling office in Bengaluru Kumar Jeetendra | March 20, 2020 Biocon NSE 8.54 % on Friday said it has gotten the establishment inspection report (EIR) from US wellbeing controller for the post-endorsement and goodt manufacturing practice (GMP) investigation of its little particles producing office in Bengaluru. “The EIR has been shut with an voluntary activity showed (VAI) grouping for the perceptions, the organization representative said …
USFDA issues cautioning letter to Cipla for Goa plant Kumar Jeetendra | March 20, 2020 The US Food and Drug Administration (USFDA) has given an admonition letter to sedate major Cipla for damaging current great assembling practice standards at its Goa-based plant. In a letter to organization’s Managing Director and Global CEO Umang Vohra, the USFDA said overseers during September 16-27, 2019, had discovered noteworthy deviations from standard assembling rehearses …
Pharma shares advance; Cadila Healthcare floods 15% Kumar Jeetendra | March 20, 2020 Pharma shares were exchanging the green in Friday’s meeting with their sectoral list exchanging higher. Portions of Cadila Healthcare (up 15.09 percent), Dr Reddys Laboratories (up 7.41 percent), Cipla (up 5.8 percent), Biocon (up 5.63 percent), Glenmark Pharmaceuticals (up 4.98 percent), Divis Laboratories (up 4.87 percent), Aurobindo Pharma (up 4.34 percent), Sun Pharmaceutical Industries (up …
Pfizer and BioNTech declare joint advancement of a potential COVID-19 antibody Kumar Jeetendra | March 19, 2020 Pharma mammoth Pfizer declared on Tuesday that it’s dealing with a potential COVID-19 antibody with BioNTech, a German organization taking a shot at new sorts of immunotherapy medicines. The joint exertion, affirmed Tuesday by means of a marked letter of aim, will see the two accomplices cooperate on an envoy RNA-based antibody that will try …
